Cargando…
Comparison of two melphalan protocols and evaluation of outcome and prognostic factors in multiple myeloma in dogs
BACKGROUND: Multiple myeloma (MM) in dogs typically is treated with melphalan. A daily melphalan dosing schedule reportedly is well tolerated and associated with favorable outcome. Although anecdotally a pulse dose regimen has resulted in successful responses, little long‐term outcome and safety dat...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980396/ https://www.ncbi.nlm.nih.gov/pubmed/29566439 http://dx.doi.org/10.1111/jvim.15084 |